tradingkey.logo
tradingkey.logo
Search

Bristol-Myers Squibb Co

BMY
Add to Watchlist
66.820USD
-1.270-1.87%
Close 09-04 16:00ET
136.46BMarket Cap
18.70P/E TTM

BMY Financials

See Bristol-Myers Squibb Co's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Bristol-Myers Squibb Co Earnings Date

Latest Release
Jul 30, 2026
EPS / Forecast
1.62/1.59
Revenue / Forecast
12.97B/11.75B
Period
FY2025 Earnings
Revenue(YoY)
48.19B
-0.22%
EPS(YoY)
3.47
178.56%
Analyst Rating
BUY
2026/09/06
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
152.34%1.62
8.62%1.31
1406.65%0.53
81.04%1.08
-22.33%0.64
120.54%1.21
-95.92%0.04
-36.29%0.60
-16.32%0.83
-646.35%-5.89
-9.33%0.87
--0.94
--0.99
--1.08
--0.96
--2.01
----
----
----
----
Revenue
5.74%12.97B
2.57%11.49B
1.30%12.50B
2.77%12.22B
0.56%12.27B
-5.60%11.20B
7.54%12.34B
8.44%11.89B
8.69%12.20B
4.66%11.87B
0.62%11.48B
-2.25%10.97B
-5.56%11.23B
-2.67%11.34B
-4.83%11.41B
-3.49%11.22B
1.57%11.89B
5.19%11.65B
8.29%11.98B
10.28%11.62B
Net Profit
153.21%3.32B
9.00%2.68B
1409.72%1.09B
81.75%2.20B
-22.02%1.31B
120.62%2.46B
-95.91%72.00M
-37.19%1.21B
-18.96%1.68B
-626.57%-11.91B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
77.00%2.26B
-14.76%2.02B
3.88%1.61B
34.69%1.42B
-36.76%1.28B
123.66%2.37B
-17.41%1.55B
Net Margin
138.85%25.56%
6.05%23.31%
1309.37%8.68%
75.78%17.96%
-22.46%10.70%
121.90%21.98%
-95.99%0.62%
-42.07%10.22%
-25.40%13.80%
-601.90%-100.36%
-13.53%15.35%
--17.64%
--18.50%
--20.00%
--17.75%
--12.43%
----
----
----
----
Gross Margin
3.25%68.03%
1.35%66.53%
8.44%65.34%
18.57%66.10%
17.97%65.88%
18.05%65.65%
6.53%60.26%
-1.71%55.75%
2.29%55.85%
-3.25%55.61%
-0.59%56.57%
--56.72%
--54.60%
--57.48%
--56.90%
--57.55%
----
----
----
----
Debt to assets ratio
-5.29%49.20%
-4.41%51.41%
-6.55%50.10%
-4.83%50.55%
-6.15%51.95%
-4.34%53.78%
28.28%53.61%
28.91%53.11%
37.35%55.35%
40.12%56.22%
2.92%41.80%
--41.20%
--40.30%
--40.12%
--40.61%
--39.82%
----
----
----
----
Revenue
5.74%12.97B
2.57%11.49B
1.30%12.50B
2.77%12.22B
0.56%12.27B
-5.60%11.20B
7.54%12.34B
8.44%11.89B
8.69%12.20B
4.66%11.87B
0.62%11.48B
-2.25%10.97B
-5.56%11.23B
-2.67%11.34B
-4.83%11.41B
-3.49%11.22B
1.57%11.89B
5.19%11.65B
8.29%11.98B
10.28%11.62B
Operating profit
6.33%4.87B
-2.02%3.98B
38.56%4.20B
59.86%4.42B
49.98%4.58B
50.87%4.07B
16.12%3.03B
1.84%2.77B
21.10%3.05B
-10.29%2.69B
2.59%2.61B
-0.77%2.71B
-21.24%2.52B
-5.83%3.00B
-8.75%2.54B
-8.37%2.74B
7.89%3.20B
25.99%3.19B
143.79%2.79B
52.19%2.99B
Net Profit
153.21%3.32B
9.00%2.68B
1409.72%1.09B
81.75%2.20B
-22.02%1.31B
120.62%2.46B
-95.91%72.00M
-37.19%1.21B
-18.96%1.68B
-626.57%-11.91B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
77.00%2.26B
-14.76%2.02B
3.88%1.61B
34.69%1.42B
-36.76%1.28B
123.66%2.37B
-17.41%1.55B
Current assets
-13.98%28.58B
-11.61%27.21B
-1.31%29.39B
26.91%35.63B
23.55%33.22B
7.37%30.78B
-6.26%29.78B
1.60%28.07B
-4.22%26.89B
5.84%28.67B
16.49%31.77B
3.12%27.63B
-7.00%28.07B
-10.08%27.09B
-18.01%27.27B
-14.78%26.80B
3.51%30.19B
11.10%30.12B
10.17%33.26B
-8.27%31.44B
Total current liabilities
-32.22%18.66B
-20.41%19.16B
-1.50%23.42B
24.29%28.14B
18.32%27.53B
-6.78%24.07B
6.79%23.77B
-3.51%22.64B
15.46%23.27B
35.30%25.82B
1.70%22.26B
23.94%23.46B
-3.66%20.15B
-16.37%19.09B
0.10%21.89B
-11.79%18.93B
10.13%20.91B
31.68%22.82B
14.61%21.87B
4.87%21.46B
Total assets
-7.44%87.63B
-6.44%86.48B
-2.77%90.04B
3.44%96.89B
0.03%94.68B
-6.67%92.43B
-2.69%92.60B
2.64%93.67B
1.24%94.65B
5.04%99.03B
-1.72%95.16B
-7.06%91.26B
-6.84%93.49B
-8.50%94.28B
-11.43%96.82B
-11.45%98.20B
-9.42%100.36B
-8.36%103.03B
-7.74%109.31B
-11.66%110.89B
Total liabilities
-15.38%65.31B
-11.48%66.37B
-6.14%71.53B
2.38%78.29B
-0.50%77.19B
-9.10%74.98B
16.05%76.22B
22.94%76.47B
26.23%77.58B
32.19%82.48B
-0.04%65.67B
-4.98%62.20B
-9.21%61.46B
-12.60%62.40B
-10.38%65.70B
-11.07%65.46B
-8.42%67.70B
-4.51%71.39B
-9.05%73.31B
-2.25%73.61B
Total equity
27.62%22.32B
15.21%20.10B
12.92%18.51B
8.14%18.60B
2.46%17.49B
5.44%17.45B
-44.42%16.39B
-40.82%17.20B
-46.71%17.07B
-48.10%16.55B
-5.25%29.48B
-11.22%29.06B
-1.93%32.03B
0.76%31.89B
-13.58%31.12B
-12.20%32.73B
-11.43%32.66B
-16.00%31.64B
-4.95%36.01B
-25.77%37.28B
Net operating income
-13.38%3.39B
-43.50%1.10B
-55.53%1.97B
12.88%6.31B
68.40%3.92B
-31.05%1.95B
4.40%4.44B
17.68%5.59B
23.26%2.33B
-4.58%2.83B
28.61%4.25B
28.86%4.75B
-16.54%1.89B
-22.09%2.97B
-18.51%3.31B
-29.98%3.69B
-26.11%2.26B
-0.31%3.81B
10.54%4.06B
132.29%5.27B
Net investment
-241.23%-1.61B
73.75%-131.00M
-643.88%-1.46B
-677.17%-1.70B
64.14%-473.00M
97.46%-499.00M
85.44%-196.00M
46.59%-219.00M
-300.91%-1.32B
-9241.90%-19.62B
-210.96%-1.35B
80.30%-410.00M
-13.84%-329.00M
-321.05%-210.00M
202.49%1.21B
-113.22%-2.08B
-260.56%-289.00M
166.43%95.00M
103.31%401.00M
-358.22%-976.00M
Net financing
-43.25%-2.63B
-57.10%-1.56B
-267.17%-6.03B
61.32%-1.49B
54.36%-1.84B
-106.78%-993.00M
-269.80%-1.64B
25.35%-3.85B
-85.14%-4.02B
580.13%14.64B
129.79%967.00M
-13.58%-5.16B
38.27%-2.17B
46.05%-3.05B
18.17%-3.25B
-155.22%-4.54B
-10.62%-3.52B
22.51%-5.65B
-213.90%-3.97B
31.19%-1.78B

FAQs

What is the total revenue of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its total revenue reached 48.19B, with a year-on-year change of 48.30B.

What are the current assets of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its current assets were 29.39B, with a year-on-year change of -1.31.

What are the total assets of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its total assets of Bristol-Myers Squibb Co were 90.04B, with a year-on-year change of -2.77.

What are the total liabilities of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its total liabilities of Bristol-Myers Squibb Co were 71.53B, with a year-on-year change of -6.14.

What is the total equity of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its total equity of Bristol-Myers Squibb Co was 18.51B, with a year-on-year change of 12.92.

What is the net operating income of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its net operating income of Bristol-Myers Squibb Co was 17.26B, with a year-on-year change of 49.54.

What is the net investment of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its net investment of Bristol-Myers Squibb Co was -4.13B, with a year-on-year change of 80.65.

What is the net financing of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its net financing of Bristol-Myers Squibb Co was -10.35B, with a year-on-year change of -301.83.

What is the Earnings Per Share (EPS) of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its Earnings Per Share (EPS) was 3.47, with a year-on-year change of 178.56.

What is the net income of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its net income was 7.05B, with a year-on-year change of 178.83.

What is the net margin of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its net profit margin was 14.64, with a year-on-year change of 179.15.

What is the gross margin of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its gross margin was 65.74, with a year-on-year change of 15.55.

What is the debt-to-asset ratio of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its debt-to-asset ratio was 50.10, with a year-on-year change of -6.55.

What is the Return on Equity (ROE) of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its Return on Equity (ROE) was 40.53, with a year-on-year change of 203.65.

What is the Return on Assets (ROA) of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its Return on Assets (ROA) was 7.73, with a year-on-year change of 181.19.

What is the operating profit of Bristol-Myers Squibb Co?

According to Bristol-Myers Squibb Co's FY2025 earnings report, its operating profit was 17.26B, with a year-on-year change of 49.54.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.